Vesitirim 1 mg/ml oral suspension Ireland - English - HPRA (Health Products Regulatory Authority)

vesitirim 1 mg/ml oral suspension

astellas pharma co. limited - solifenacin succinate - oral suspension - 1 milligram(s)/millilitre - drugs for urinary frequency and incontinence; solifenacin - urologicals, drugs for urinary frequency and incontinence - symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

Advagraf Prolonged Release Hard Capsules 0.5 mg Singapore - English - HSA (Health Sciences Authority)

advagraf prolonged release hard capsules 0.5 mg

astellas pharma singapore pte. ltd. - tacrolimus monohydrate 0.51 mg eqv anhydrous tacrolimus 0.5 mg - capsule, extended release - 0.5 mg - tacrolimus monohydrate 0.51 mg eqv anhydrous tacrolimus 0.5 mg 0.5 mg

Advagraf Prolonged Release Hard Capsules 1 mg Singapore - English - HSA (Health Sciences Authority)

advagraf prolonged release hard capsules 1 mg

astellas pharma singapore pte. ltd. - tacrolimus monohydrate 1.02 mg eqv anhydrous tacrolimus 1.0 mg - capsule, extended release - 1.0 mg - tacrolimus monohydrate 1.02 mg eqv anhydrous tacrolimus 1.0 mg 1.0 mg

Advagraf Prolonged Release Hard Capsules 5 mg Singapore - English - HSA (Health Sciences Authority)

advagraf prolonged release hard capsules 5 mg

astellas pharma singapore pte. ltd. - tacrolimus monohydrate 5.1 mg eqv anhydrous tacrolimus 5.0 mg - capsule, extended release - 5.0 mg - tacrolimus monohydrate 5.1 mg eqv anhydrous tacrolimus 5.0 mg 5.0 mg

ADVAGRAF 0.5 MG Israel - English - Ministry of Health

advagraf 0.5 mg

astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 0.5 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.

ADVAGRAF 1 MG Israel - English - Ministry of Health

advagraf 1 mg

astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 1 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.

ADVAGRAF 3 MG Israel - English - Ministry of Health

advagraf 3 mg

astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 3 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.

ADVAGRAF 5 MG Israel - English - Ministry of Health

advagraf 5 mg

astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 5 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.

PROGRAF 1 MG Israel - English - Ministry of Health

prograf 1 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

PROGRAF 1 MG Israel - English - Ministry of Health

prograf 1 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.